Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease
Clinical trial NCT01752985 · TERMINATED
Trial details
- NCT number
- NCT01752985
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-18
- Primary completion
- 2015-06-30
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.